Aberrant expression of TAL1, resulting from genetic anomalies such as chromosomal translocations, has been implicated in the development of hematologic malignancies, notably T-cell acute lymphoblastic leukemia (T-ALL)29,30. Here, TAL1 is linked to hematologic disorder.